A nanoparticle-based combination chemotherapy delivery system for enhanced tumor killing by dynamic rewiring of signaling pathways. - Wikidata - awgldk - TriplyDB

A nanoparticle-based combination chemotherapy delivery system for enhanced tumor killing by dynamic rewiring of signaling pathways.

A nanoparticle-based combination chemotherapy delivery system for enhanced tumor killing by dynamic rewiring of signaling pathways.

http://www.wikidata.org/entity/Q34066773

about

Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy Inflammation-induced cell proliferation potentiates DNA damage-induced mutations in vivo Targeting cancer cells in the tumor microenvironment: opportunities and challenges in combinatorial nanomedicine.Spatiotemporally and Sequentially-Controlled Drug Release from Polymer Gatekeeper-Hollow Silica Nanoparticles.Platinum covalent shell cross-linked micelles designed to deliver doxorubicin for synergistic combination cancer therapy Microemulsion-based synergistic dual-drug codelivery system for enhanced apoptosis of tumor cells.Tumor-Targeted Synergistic Blockade of MAPK and PI3K from a Layer-by-Layer Nanoparticle.Constitutive activation of STAT3 in breast cancer cells: A review.Nanoparticle-Hydrogel: A Hybrid Biomaterial System for Localized Drug Delivery Photonanomedicine: a convergence of photodynamic therapy and nanotechnology.Opportunities and challenges in combination gene cancer therapy.Improving Cancer Chemoradiotherapy Treatment by Dual Controlled Release of Wortmannin and Docetaxel in Polymeric Nanoparticles.Recent advances of cocktail chemotherapy by combination drug delivery systems.Schedule-dependent interaction between anticancer treatments.Lung cancer nanomedicine: potentials and pitfalls.CCR 20th Anniversary Commentary: Prospects and Challenges of Therapeutic Nanoparticles in Cancer.Nanoparticulation improves bioavailability of Erlotinib.Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer.Programmable biomaterials for dynamic and responsive drug delivery.Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer.Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis.Combinatorial nanotherapeutics: rewiring, then killing, cancer cells.The potential of multi-compound nanoparticles to bypass drug resistance in cancer.Sequential delivery of erlotinib and doxorubicin for enhanced triple negative Breast cancer treatment using polymeric nanoparticle.Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice.Delayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy.Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma.Single-trigger dual-responsive nanoparticles for controllable and sequential prodrug activation.Thermo-Sensitive Liposome co-Loaded of Vincristine and Doxorubicin Based on Their Similar Physicochemical Properties had Synergism on Tumor Treatment.Stimuli-free programmable drug release for combination chemo-therapy.Cell membrane wrapping of a spherical thin elastic shell.Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles.Investigation on Physicochemical Characteristics of a Nanoliposome-Based System for Dual Drug Delivery.Cellular hysteresis as a principle to maximize the efficacy of antibiotic therapy Multifunctional Nanosystem for Targeted and Controlled Delivery of Multiple Chemotherapeutic Agents for the Treatment of Drug-Resistant Breast Cancer

P2860

Q27004011-05977266-0FF1-4D28-977D-7F079801FE5E Q27311572-EDC0760E-9D9C-4398-9D30-E16A690731FF Q30279055-6E837F8E-2CB1-4093-AAB2-843321B426E7 Q33594253-C7636E4F-3C5C-49FC-9D4E-A44F444ADB1F Q33713159-612DC9EF-0DBF-47D8-BC1D-9B87A377B0D4 Q35087984-A6C3B6A7-6AC2-41AF-9C37-C7DBFB2D6BC8 Q36219160-1C2F0E9A-172E-4A5C-A376-ADDC9C35A6F7 Q36711689-10BA0425-5CE7-4493-9434-684E0D51B9A6 Q36936204-4AD9C3AA-372C-4BE8-8F10-0084057890CA Q37115994-F9F4F969-327F-43EB-9BC0-066C10E51D38 Q37118663-AEAA7540-58A1-4B78-BEEF-4476CABC9033 Q37188521-5130EFA4-75BC-4F83-9F03-7170A1F57C3E Q37206908-B0F9F676-7522-44B1-8300-13BE7CC437EF Q37566678-78254E6D-086C-4973-BA55-B85279878E70 Q38608622-07F21A74-4753-4EA0-A9A5-515385F4E0BB Q38608825-64A98C44-608D-434C-92BE-065312AE91D0 Q38701944-93D8B499-5BC7-4B19-A3B6-B4D8DEE350C9 Q38809683-DC85DE59-9E5A-49A1-AD58-1FA84908F212 Q38837032-56DA8AF4-9518-46C6-9BA9-AE919C0CE2A3 Q41514180-89335E0C-36CA-4EFC-AEA2-EE96FB3CE35C Q42176588-A279FD57-477C-4CBA-A50A-9AF3DFEF7DB6 Q45293948-E427F1FA-7507-43DB-8D03-943569D741A4 Q46641923-7592112B-3648-42F4-85E7-4792D6B7440B Q47114290-7C001E9A-B2A4-44F1-8DC0-F1739C99CBAD Q47138564-2A9E8380-B1CB-477D-A7F4-B9F6519E1C5B Q47148643-0DD840D4-DCA2-4C0B-BAAE-E55DA9F5CA49 Q47403872-45D52DF1-5363-45B7-B31D-55BD9EA703FE Q48206548-8DD27120-3E05-4FDB-A896-CEBCA315725F Q50543302-6C29EEF4-ABC9-47A0-BAA9-DDD5A3EBB057 Q53123294-3E1590F1-358A-4AEC-A2DA-C3ADBD22B584 Q53288917-368F7401-2457-4573-845E-3C1F745F265B Q53355893-73519D63-0E1E-466C-8134-EA07934C2C5C Q54957650-F47CBE7B-E2C9-496E-B234-644916C9980F Q55207437-A3314520-9051-4800-A01F-E414EF091E18 Q58745077-07A7C940-ADD5-4921-8767-4EA0A02440ED Q58776517-E66DEC37-9860-4850-AA27-8D10C6AD2175

P2860

A nanoparticle-based combination chemotherapy delivery system for enhanced tumor killing by dynamic rewiring of signaling pathways.

http://www.wikidata.org/entity/Q34066773

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A nanoparticle-based combinati ...... ewiring of signaling pathways.

@ast

A nanoparticle-based combinati ...... ewiring of signaling pathways.

@en

A nanoparticle-based combinati ...... ewiring of signaling pathways.

@nl

type

label

A nanoparticle-based combinati ...... ewiring of signaling pathways.

@ast

A nanoparticle-based combinati ...... ewiring of signaling pathways.

@en

A nanoparticle-based combinati ...... ewiring of signaling pathways.

@nl

prefLabel

A nanoparticle-based combinati ...... ewiring of signaling pathways.

@ast

A nanoparticle-based combinati ...... ewiring of signaling pathways.

@en

A nanoparticle-based combinati ...... ewiring of signaling pathways.

@nl

P1433

Q34066773-F3FA6D52-C504-4298-8378-8A73DFAA1AA2

P1476

Q34066773-DC143BAD-A56A-4C9E-B7B2-4DF439FA71C2

P2093

Q34066773-1D9A6D7A-B074-40A4-A9A9-06682F3D1442

Q34066773-44FCF111-73A8-4983-AF57-F43D2726566C

Q34066773-7A24A869-649F-4625-A47B-57D0AC5FC40E

Q34066773-7D411E14-43C6-4006-8C4D-6EFABE187E4D

Q34066773-9F99946F-52A1-4007-BB84-D7270BB7D8AB

Q34066773-A78BE02B-8CCB-4500-8869-0CD9A57383E0

Q34066773-CF1EE661-9902-4A14-81A3-0BE7D066EDBF

P2860

Q34066773-179267F2-2AE5-4896-8862-7E9D6DC6DFB0

Q34066773-1DDC3677-03C6-4543-A67F-FCAE9C6F0A4A

Q34066773-34F9AD0C-D26B-4CD8-B100-F178B7B668B6

Q34066773-36E6A944-065C-4638-8098-35DBF9FBF12B

Q34066773-4FA1A75B-0B0F-441E-9B65-4061FE3A5244

Q34066773-50E71DE7-7486-4883-91D7-C413085C5E85

Q34066773-52F6F302-87E8-485F-961E-F51C7E18C659

Q34066773-534AA269-0273-4605-9D27-162EEBD13A29

Q34066773-5B29FCAC-D5E0-45D5-A508-6DF392E58D20

Q34066773-62A396CE-8065-4624-8E74-F5963A558A58

P304

Q34066773-B8E0757B-34DB-4260-983E-670F01F36311

P31

Q34066773-C1974790-E5AD-4614-AA5F-FA0D59BA799B

P356

Q34066773-A0F5D083-E7DD-4E4E-837F-E59724901B58

P433

Q34066773-B309F0FA-6B69-4E98-A842-4BDEAB8FCA81

P478

Q34066773-CD651845-D64B-4883-A117-A32AB7091E4E

P50

Q34066773-1D84BC5D-6EDA-489B-814B-C4D6B3899568

Q34066773-FA481600-9341-4B67-9F0E-BDADBA69877F

P577

Q34066773-C3C8BFB5-7C59-4B5C-BC06-60ED6075243E

P5875

Q34066773-B9540FED-1FD1-45F5-8985-1BAD1BAB9393

P698

Q34066773-4359AED7-F2C1-45FC-A6B1-3A5A8AB770AC

P921

Q34066773-B91DFF47-9017-4778-A872-9682287A6FE5

Q34066773-DFF41A86-802F-488F-A0CD-EA3A159365FD

P932

Q34066773-9B64E83C-C692-417F-81CF-C70E8DD709D2

P356

SCISIGNAL.2005261

P1433

Science Signaling

P1476

A nanoparticle-based combinati ...... rewiring of signaling pathways

@en

P2093

Elise Siouve

http://www.w3.org/2001/XMLSchema#string

Kevin E Shopsowitz

http://www.w3.org/2001/XMLSchema#string

Michael B Yaffe

http://www.w3.org/2001/XMLSchema#string

Nisarg J Shah

http://www.w3.org/2001/XMLSchema#string

Paula T Hammond

http://www.w3.org/2001/XMLSchema#string

Stephen W Morton

http://www.w3.org/2001/XMLSchema#string

Zhou J Deng

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Drug discovery using chemical systems biology: weak inhibition of multiple kinases may contribute to the anti-cancer effect of nelfinavir

Recent advances with liposomes as pharmaceutical carriers

Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting

Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.

Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks.

Comparative properties and methods of preparation of lipid vesicles (liposomes).

Folate-mediated delivery of macromolecular anticancer therapeutic agents.

Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy

Cytokine-induced signaling networks prioritize dynamic range over signal strength.

P304

ra44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCISIGNAL.2005261

http://www.w3.org/2001/XMLSchema#string

P433

325

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262306933

http://www.w3.org/2001/XMLSchema#string

P698

24825919

http://www.w3.org/2001/XMLSchema#string

P921

P932

4138219

http://www.w3.org/2001/XMLSchema#string